Wang Chih-Liang, Tsai Ying-Huang, Huang Chung-Chi, Wu Yau-Kwang, Ye Ming-Zhu, Chou Hsiu-Min, Shu Shih-Chun, Lin Meng-Chih
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chang Gung Memorial Hospital, Niaosung Shiang, Kaohsiung, Taiwan, R.O.C.
Chang Gung Med J. 2007 Jan-Feb;30(1):53-61.
There is not enough evidence to determine the most appropriate treatment of postextubation stridor. Although the cuff leak test is a simple method to predict postextubation stridor, little is known about its use in monitoring the effects of steroid treatment for this complication. The aim of this study was to evaluate the effect of steroids on postextubation stridor based on the clinical response and the cuff leak test.
A cohort of 110 translaryngeal intubated patients in the medical intensive care unit (ICU) were enrolled. A cuff leak test was conducted before extubation. Patients developing postextubation stridor were intravenously given 5 mgs of dexamethasone every 8 hours for 3 days. The clinical response and cuff leak volume before and after steroid treatment were gathered for analysis.
The incidence of postextubation stridor was 18.2% (20/110). Fifty-five percent of patients (11/20) with stridor needed reintubation. Overall, 80% of patients (16/20) with postextubation stridor improved with steroid treatment. The leak volume significantly increased after treatment (152.4 +/- 109.6 ml vs. 29.9 +/- 35.7 ml, p = 0.012); stridor did not recur in 64% of reintubated patients (7/11). A threshold leak volume of less than 88 ml predicted the occurrence of stridor (positive predictive value, 54.5%; negative predictive value, 90.9%). Postextubation stridor was associated with the female gender and lower leak volumes (p = 0.007 and 0.003, respectively).
Corticosteroids improve postextubation stridor. The cuff leak test accurately predicts the absence of stridor and is a non-invasive method of monitoring for regression of laryngeal edema after steroid treatment. Steroid treatment should be considered for patients developing postextubation stridor.
目前尚无足够证据确定拔管后喘鸣的最恰当治疗方法。尽管套囊漏气试验是预测拔管后喘鸣的一种简单方法,但对于其在监测类固醇治疗该并发症效果方面的应用却知之甚少。本研究的目的是基于临床反应和套囊漏气试验评估类固醇对拔管后喘鸣的影响。
纳入医学重症监护病房(ICU)中110例经喉插管患者。在拔管前进行套囊漏气试验。发生拔管后喘鸣的患者每8小时静脉给予5毫克地塞米松,共3天。收集类固醇治疗前后的临床反应及套囊漏气量进行分析。
拔管后喘鸣的发生率为18.2%(20/110)。55%的喘鸣患者(11/20)需要再次插管。总体而言,80%的拔管后喘鸣患者经类固醇治疗后病情改善。治疗后漏气量显著增加(152.4±109.6毫升对29.9±35.7毫升,p = 0.012);64%的再次插管患者(